Parkinson's Disease and Related Disorders Part II
Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab)By
- William Koller, MD, PhD, Department of Neurology, UNC-Chapel Hill, NC, USA
- Eldad Melamed, MD, Department of Neurology, Rabin Medical Center, Petaq Tiqva, Israel
This volume provides comprehensive information on Parkinsons disease and related disorders, a group of diseases that are among the most common in the field of neurodegenerative study.
Through a high-level presentation of new research regarding these diseases, this handbook will give clinicians and neuroscientists alike a better understanding of the dramatic pharmacological advances made in the management of Parkinsons disease, and the profound observations that have altered the medical communitys approach to other degenerative disorders of the nervous system.
Practitioners, researchers, and medical personnel will gain exciting insights into recent developments that form the basis for new therapeutic strategies and management protocols for the various neurological disorders that present with Parkinsonism.
Neurologists and research neuroscientists
Handbook of Clinical Neurology
Published: June 2007
- Section 5: Treatment of Parkinson's disease
Physical therapy in Parkinsons disease. Neuroprotection in Parkinsons disease: clinical trials. Levodopa. Dopamine agonists. Monoamine oxidase A and B inhibitors in Parkinsons disease. Anticholinergic medications. Antiglutamatergic drugs in the treatment of Parkinsons disease. Investigational drugs. The importance of patients groups and collaboration
Section 6: Complications of therapy
Motor and non-motor fluctuations. Levodopa-induced dyskinesias in Parkinsons disease. Treatment induced mental changes in Parkinsons disease.
Section 7 Surgical treatment
Ablative surgery for the treatment of Parkinsons disease. Deep brain stimulation. Transplantation. Gene therapy approaches for the treatment of Parkinsons disease.
Section 8: Other parkinsonian disease syndromes
Multiple system atrophy. Progressive supranuclear palsy. Corticobasal degeneration. Infectious basis to the pathogenesis of Parkinsons disease. Toxic causes of Parkinsons disease. Drug induced parkinsonism. Vascular parkinsonism. Old age and Parkinsons disease. Other degenerative processes. Hydrocephalus and structural lesions. Calcification of the basal ganglia. Trauma and Parkinsons disease. Psychogenic parkinsonism. Parkinsonism and dystonia. Dementia with Lewy bodies. Myoclonus and parkinsonism.